Published in PLoS One on March 26, 2013
AIRE-Deficient Patients Harbor Unique High-Affinity Disease-Ameliorating Autoantibodies. Cell (2016) 2.19
A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes. Diabetes (2014) 1.50
Autoimmune manifestations in aged mice arise from early-life immune dysregulation. Sci Transl Med (2016) 1.40
A minor subset of Batf3-dependent antigen-presenting cells in islets of Langerhans is essential for the development of autoimmune diabetes. Immunity (2014) 1.11
Heterogeneity and Lobularity of Pancreatic Pathology in Type 1 Diabetes during the Prediabetic Phase. J Histochem Cytochem (2015) 1.02
Population dynamics of islet-infiltrating cells in autoimmune diabetes. Proc Natl Acad Sci U S A (2015) 0.94
Pathogenic CD4⁺ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J Exp Med (2013) 0.92
The central role of antigen presentation in islets of Langerhans in autoimmune diabetes. Curr Opin Immunol (2013) 0.90
The Role of Dendritic Cell Subsets and Innate Immunity in the Pathogenesis of Type 1 Diabetes and Other Autoimmune Diseases. Front Immunol (2015) 0.85
Insulitis in human type 1 diabetes: a comparison between patients and animal models. Semin Immunopathol (2014) 0.85
Induction of indoleamine 2, 3-dioxygenase in human dendritic cells by a cholera toxin B subunit-proinsulin vaccine. PLoS One (2015) 0.82
Transcriptional regulation of chemokine genes: a link to pancreatic islet inflammation? Biomolecules (2015) 0.81
Inhibition of Ca2+-independent phospholipase A2β (iPLA2β) ameliorates islet infiltration and incidence of diabetes in NOD mice. Diabetes (2014) 0.81
B-lymphocytes expressing an immunoglobulin specificity recognizing the pancreatic ß-cell autoantigen peripherin are potent contributors to type 1 diabetes development in NOD mice. Diabetes (2016) 0.79
ZnT8-reactive T cells are weakly pathogenic in NOD mice but can participate in diabetes under inflammatory conditions. Diabetes (2014) 0.79
Use of autoantigen-loaded phosphatidylserine-liposomes to arrest autoimmunity in type 1 diabetes. PLoS One (2015) 0.75
Antigen presentation events during the initiation of autoimmune diabetes in the NOD mouse. J Autoimmun (2016) 0.75
Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model. Front Immunol (2016) 0.75
Rapid, high efficiency isolation of pancreatic ß-cells. Sci Rep (2015) 0.75
The role of islet antigen presenting cells and the presentation of insulin in the initiation of autoimmune diabetes in the NOD mouse. Immunol Rev (2016) 0.75
Anti-coreceptor therapy drives selective T cell egress by suppressing inflammation-dependent chemotactic cues. JCI Insight (2016) 0.75
Macrophages and dendritic cells in islets of Langerhans in diabetic autoimmunity: a lesson on cell interactions in a mini-organ. Curr Opin Immunol (2016) 0.75
The Importance of Dendritic Cells in Maintaining Immune Tolerance. J Immunol (2017) 0.75
E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes. PLoS One (2015) 0.75
Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-α signaling. Proc Natl Acad Sci U S A (2017) 0.75
The innate immune receptor MDA5 limits rotavirus infection but promotes cell death and pancreatic inflammation. EMBO J (2017) 0.75
Cutting Edge: Origins, Recruitment, and Regulation of CD11c(+) Cells in Inflamed Islets of Autoimmune Diabetes Mice. J Immunol (2017) 0.75
The islet-resident macrophage is in an inflammatory state and senses microbial products in blood. J Exp Med (2017) 0.75
Type 1 Interferons Potentiate Human CD8(+) T Cell Cytotoxicity Through a STAT4 and Granzyme B Dependent Pathway. Diabetes (2017) 0.75
Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment. Front Endocrinol (Lausanne) (2017) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res (2003) 52.74
KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res (1999) 40.62
GenePattern 2.0. Nat Genet (2006) 29.07
Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics (2006) 22.61
Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature (2008) 12.45
Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes (1967) 11.63
HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature (1987) 10.70
Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol (2005) 7.74
The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol (2008) 7.23
A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res (2003) 6.76
Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol (2008) 6.17
Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med (1986) 6.11
Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity (2008) 6.08
What is principal component analysis? Nat Biotechnol (2008) 5.28
beta-Cell death during progression to diabetes. Nature (2001) 4.61
Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med (1999) 3.85
Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol (1995) 3.71
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat Med (2007) 3.45
A weak signal for strong responses: interferon-alpha/beta revisited. Nat Rev Mol Cell Biol (2001) 3.39
GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res (2012) 3.29
Etiology of type 1 diabetes. Immunity (2010) 3.28
Pscan: finding over-represented transcription factor binding site motifs in sequences from co-regulated or co-expressed genes. Nucleic Acids Res (2009) 3.04
A trans-acting locus regulates an anti-viral expression network and type 1 diabetes risk. Nature (2010) 2.88
Immune cell crosstalk in type 1 diabetes. Nat Rev Immunol (2010) 2.26
Constitutive type I interferon modulates homeostatic balance through tonic signaling. Immunity (2012) 2.23
Systematic identification of type I and type II interferon-induced antiviral factors. Proc Natl Acad Sci U S A (2012) 2.18
How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity (2009) 2.15
Early window of diabetes determinism in NOD mice, dependent on the complement receptor CRIg, identified by noninvasive imaging. Nat Immunol (2012) 2.11
Pancreatic lymph nodes are required for priming of beta cell reactive T cells in NOD mice. J Exp Med (2002) 2.02
Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. Proc Natl Acad Sci U S A (2004) 1.96
BioNet: an R-Package for the functional analysis of biological networks. Bioinformatics (2010) 1.93
A protocol for islet isolation from mouse pancreas. Nat Protoc (2009) 1.89
Chromosomal location of the Ly-49 (A1, YE1/48) multigene family. Genetic association with the NK 1.1 antigen. J Immunol (1990) 1.74
Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor. Blood (2010) 1.69
Interferon expression in the pancreases of patients with type I diabetes. Diabetes (1995) 1.69
Induction of type I diabetes by interferon-alpha in transgenic mice. Science (1993) 1.68
Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice. Proc Natl Acad Sci U S A (2008) 1.66
Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity (2012) 1.61
Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest (2005) 1.60
Islet filtration: a simple and rapid new purification procedure that avoids ficoll and improves islet mass and function. Transplantation (2002) 1.58
Concordance for islet autoimmunity among monozygotic twins. N Engl J Med (2008) 1.53
Characterization of the interferon-producing cell in mice infected with Listeria monocytogenes. PLoS Pathog (2009) 1.50
Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A (2008) 1.50
An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity (2012) 1.50
Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A (2011) 1.31
The long and winding road to understanding and conquering type 1 diabetes. Immunity (2010) 1.24
Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Genomics (2005) 1.19
Amplification of autoimmune response through induction of dendritic cell maturation in inflamed tissues. J Immunol (2009) 1.18
Progression to islet destruction in a cyclophosphamide-induced transgenic model: a microarray overview. Diabetes (2004) 1.17
Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci U S A (2011) 1.13
Mouse pancreatic endocrine cell transcriptome defined in the embryonic Ngn3-null mouse. Diabetes (2008) 1.09
Islet expression of interferon-alpha precedes diabetes in both the BB rat and streptozotocin-treated mice. Immunity (1994) 1.09
Antigen presentation events in autoimmune diabetes. Curr Opin Immunol (2011) 1.08
IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J Immunol (1996) 1.03
IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol (2008) 0.98
Functional specialization of islet dendritic cell subsets. J Immunol (2012) 0.92
Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development. Int Immunol (2009) 0.88
A case of type 1 diabetes onset and recurrence of Graves' disease during pegylated interferon-α plus ribavirin treatment for chronic hepatitis C. Intern Med (2010) 0.79
Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science (2008) 7.87
T cell sensing of antigen dose governs interactive behavior with dendritic cells and sets a threshold for T cell activation. Nat Immunol (2008) 4.52
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature (2010) 3.96
CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science (2003) 3.61
Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to Listeria infection. J Exp Med (2004) 3.06
MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol (2002) 2.60
Podocytes use FcRn to clear IgG from the glomerular basement membrane. Proc Natl Acad Sci U S A (2008) 2.12
Unique autoreactive T cells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat Immunol (2010) 2.08
CD8α(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes. Immunity (2011) 1.99
Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells. Elife (2014) 1.97
DNA double-strand breaks activate a multi-functional genetic program in developing lymphocytes. Nature (2008) 1.88
Systematic discovery of TLR signaling components delineates viral-sensing circuits. Cell (2011) 1.83
CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms. Nat Immunol (2009) 1.70
Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science (2006) 1.69
Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes. J Exp Med (2006) 1.69
Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity. J Clin Invest (2005) 1.60
Listeriolysin O from Listeria monocytogenes is a lymphocyte apoptogenic molecule. J Immunol (2004) 1.58
Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells. J Exp Med (2003) 1.54
Dendritic cells in islets of Langerhans constitutively present beta cell-derived peptides bound to their class II MHC molecules. Proc Natl Acad Sci U S A (2008) 1.50
The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form. J Immunol (2007) 1.47
Register shifting of an insulin peptide-MHC complex allows diabetogenic T cells to escape thymic deletion. J Exp Med (2011) 1.45
Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J Immunol (2010) 1.43
Binding of immunogenic peptides to Ia histocompatibility molecules. 1985. J Immunol (2005) 1.42
Identification of a macrophage antigen-processing event required for I-region-restricted antigen presentation to T lymphocytes. J. Immunol. 1981. 127: 1869-1875. J Immunol (2007) 1.41
In APCs, the autologous peptides selected by the diabetogenic I-Ag7 molecule are unique and determined by the amino acid changes in the P9 pocket. J Immunol (2002) 1.32
Cellular and molecular events in the localization of diabetogenic T cells to islets of Langerhans. Proc Natl Acad Sci U S A (2011) 1.31
T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM. Immunity (2004) 1.31
Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation. Proc Natl Acad Sci U S A (2009) 1.29
Unconventional recognition of peptides by T cells and the implications for autoimmunity. Nat Rev Immunol (2012) 1.29
Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells. J Exp Med (2011) 1.28
Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization. PLoS One (2011) 1.25
In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model. Am J Pathol (2006) 1.24
Efficient stochastic simulation of reaction-diffusion processes via direct compilation. Bioinformatics (2009) 1.23
Conformational isomers of a peptide-class II major histocompatibility complex. Immunol Rev (2005) 1.22
The cellular niche of Listeria monocytogenes infection changes rapidly in the spleen. Eur J Immunol (2009) 1.21
Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. Proc Natl Acad Sci U S A (2002) 1.21
Tumor neoantigens: building a framework for personalized cancer immunotherapy. J Clin Invest (2015) 1.13
Entry of diabetogenic T cells into islets induces changes that lead to amplification of the cellular response. Proc Natl Acad Sci U S A (2011) 1.13
Thymus-blood protein interactions are highly effective in negative selection and regulatory T cell induction. J Immunol (2009) 1.13
Genome-wide siRNA screen for mediators of NF-κB activation. Proc Natl Acad Sci U S A (2012) 1.12
Amino-terminal flanking residues determine the conformation of a peptide-class II MHC complex. J Immunol (2006) 1.09
Protein-RNA interface residue prediction using machine learning: an assessment of the state of the art. BMC Bioinformatics (2012) 1.09
Antigen presentation events in autoimmune diabetes. Curr Opin Immunol (2011) 1.08
Weak proinsulin peptide-major histocompatibility complexes are targeted in autoimmune diabetes in mice. Diabetes (2008) 1.07
Dendritic cells process and present antigens across a range of maturation states. J Immunol (2003) 1.07
Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes (2004) 1.06
The wide diversity and complexity of peptides bound to class II MHC molecules. Curr Opin Immunol (2005) 1.05
Regulation of autoimmune diabetes by non-islet-specific T cells - a role for the glucocorticoid-induced TNF receptor. Eur J Immunol (2004) 1.04
Functional redundancy between thymic CD8α+ and Sirpα+ conventional dendritic cells in presentation of blood-derived lysozyme by MHC class II proteins. J Immunol (2010) 1.04
RNA sensor-induced type I IFN prevents diabetes caused by a β cell-tropic virus in mice. J Clin Invest (2011) 1.04
Do the peptide-binding properties of diabetogenic class II molecules explain autoreactivity? Curr Opin Immunol (2007) 1.03
Lymphocyte apoptosis as an immune subversion strategy of microbial pathogens. Trends Immunol (2006) 1.02
Neutrophils control the magnitude and spread of the immune response in a thromboxane A2-mediated process. J Exp Med (2013) 1.01
Distinct recognition by two subsets of T cells of an MHC class II-peptide complex. Proc Natl Acad Sci U S A (2002) 1.00
Cutting edge: H-2DM is responsible for the large differences in presentation among peptides selected by I-Ak during antigen processing. J Immunol (2003) 1.00
IFN-gamma-dependent regulatory circuits in immune inflammation highlighted in diabetes. J Immunol (2008) 0.98
Cutting edge: unique T cells that recognize citrullinated peptides are a feature of protein immunization. J Immunol (2006) 0.97
Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides. J Immunol (2007) 0.96
Listeriolysin o is strongly immunogenic independently of its cytotoxic activity. PLoS One (2012) 0.96
Unifying model for molecular determinants of the preselection Vβ repertoire. Proc Natl Acad Sci U S A (2013) 0.95
In vivo imaging of T cell priming. Sci Signal (2008) 0.95
Specificity of peptide selection by antigen-presenting cells homozygous or heterozygous for expression of class II MHC molecules: The lack of competition. Proc Natl Acad Sci U S A (2003) 0.94
First signature of islet beta-cell-derived naturally processed peptides selected by diabetogenic class II MHC molecules. J Immunol (2008) 0.94
Pathogenic CD4⁺ T cells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J Exp Med (2013) 0.92
A novel pathway of presentation by class II-MHC molecules involving peptides or denatured proteins important in autoimmunity. Mol Immunol (2012) 0.91
Cutting edge: chemical dominance does not relate to immunodominance: studies of the CD4+ T cell response to a model antigen. J Immunol (2002) 0.90
Identification of naturally processed peptides bound to the class I MHC molecule H-2Kd of normal and TAP-deficient cells. Eur J Immunol (2006) 0.90
APCs present A beta(k)-derived peptides that are autoantigenic to type B T cells. J Immunol (2003) 0.89
Following immunization antigen becomes concentrated in a limited number of APCs including B cells. J Immunol (2004) 0.89
Granzymes drive a rapid listeriolysin O-induced T cell apoptosis. J Immunol (2008) 0.89
Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1). J Immunol (2013) 0.88
Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation. J Immunol (2011) 0.87
Interaction of streptavidin-based peptide-MHC oligomers (tetramers) with cell-surface TCRs. J Immunol (2011) 0.86
Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm. Proteomics (2007) 0.86
Autoimmune diabetes mellitus--much progress, but many challenges. Adv Immunol (2008) 0.86
Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells. Proc Natl Acad Sci U S A (2005) 0.86
Chemical identification of a low abundance lysozyme peptide family bound to I-Ak histocompatibility molecules. J Biol Chem (2002) 0.85
Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells. Int Immunol (2009) 0.85
Diabetes is predicted by the beta cell level of autoantigen. J Immunol (2005) 0.85
Inhibition of VEGFR-2 reverses type 1 diabetes in NOD mice by abrogating insulitis and restoring islet function. Diabetes (2013) 0.85
Mechanisms and immunological effects of apoptosis caused by Listeria monocytogenes. Adv Immunol (2012) 0.84
Processing of proteins in autophagy vesicles of antigen-presenting cells generates citrullinated peptides recognized by the immune system. Autophagy (2012) 0.83
Solutions of burnt-bridge models for molecular motor transport. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 0.83
Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC. J Exp Med (2013) 0.83
Impact of lymphocyte apoptosis on the innate immune stages of infection. Immunol Res (2007) 0.81
Recombinant Listeria monocytogenes expressing a cell wall-associated listeriolysin O is weakly virulent but immunogenic. Infect Immun (2009) 0.81
Targeted chromatin profiling reveals novel enhancers in Ig H and Ig L chain Loci. J Immunol (2013) 0.80
Exploration of the relationship between topology and designability of conformations. J Chem Phys (2011) 0.80
Autoantibodies and CD4 T cells target a beta cell retroviral envelope protein in non-obese diabetic mice. Int Immunol (2003) 0.79
The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection. Adv Immunol (2005) 0.79
Shape-based feature matching improves protein identification via LC-MS and tandem MS. J Comput Biol (2011) 0.77